Bulletin
Investor Alert

New York Markets Open in:

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 5, 2021, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

164.60

Change

+1.76 +1.08%

Volume

Volume 682,750

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 173.59

$ 162.84

Change

-10.75 -6.19%

Day low

Day high

$156.81

$180.70

Open

52 week low

52 week high

$46.13

$189.26

Open

Insider Actions for Moderna Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/29/2021 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $182.49 per share. 1,824,900
04/29/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Disposition at $182.49 per share. 1,204,434
04/29/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Derivative/Non-derivative trans. at $20.93 per share. 138,138
04/28/2021 Stéphane Bancel
Chief Executive Officer; Director
2,000   Gift at $0 per share. 0
04/28/2021 Stéphane Bancel
Chief Executive Officer; Director
9,000   Disposition at $182.32 per share. 1,640,880
04/28/2021 Juan Andres
See remarks
5,000   Disposition at $182.32 per share. 911,600
04/28/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
04/27/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Disposition at $178.29 per share. 1,176,714
04/27/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Derivative/Non-derivative trans. at $20.93 per share. 138,138
04/26/2021 Stephen Hoge
President
5,000   Disposition at $171.77 per share. 858,850
04/26/2021 Juan Andres
See remarks
5,000   Disposition at $171.77 per share. 858,850
04/26/2021 Tal Zaks
Chief Medical Officer
100   Disposition at $179.37 per share. 17,937
04/26/2021 Tal Zaks
Chief Medical Officer
1,829   Disposition at $178.51 per share. 326,494
04/26/2021 Tal Zaks
Chief Medical Officer
900   Disposition at $177.41 per share. 159,669
04/26/2021 Tal Zaks
Chief Medical Officer
551   Disposition at $175.97 per share. 96,959
04/26/2021 Tal Zaks
Chief Medical Officer
400   Disposition at $175.03 per share. 70,012
04/26/2021 Tal Zaks
Chief Medical Officer
200   Disposition at $173.03 per share. 34,606
04/26/2021 Tal Zaks
Chief Medical Officer
1   Disposition at $171.65 per share. 171
04/26/2021 Tal Zaks
Chief Medical Officer
439   Disposition at $171.05 per share. 75,090
04/26/2021 Tal Zaks
Chief Medical Officer
580   Disposition at $169.87 per share. 98,524
04/26/2021 Stephen Hoge
President
5,000   Derivative/Non-derivative trans. at $10.9 per share. 54,500
04/26/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
04/26/2021 Tal Zaks
Chief Medical Officer
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
04/23/2021 Stéphane Bancel
Chief Executive Officer; Director
100   Disposition at $175.32 per share. 17,532
04/23/2021 Stéphane Bancel
Chief Executive Officer; Director
4,985   Disposition at $174.13 per share. 868,038
04/23/2021 Stéphane Bancel
Chief Executive Officer; Director
3,500   Disposition at $173.17 per share. 606,095
04/23/2021 Stéphane Bancel
Chief Executive Officer; Director
1,300   Disposition at $172.22 per share. 223,886
04/23/2021 Stéphane Bancel
Chief Executive Officer; Director
661   Disposition at $171.13 per share. 113,116
04/23/2021 Stéphane Bancel
Chief Executive Officer; Director
500   Disposition at $169.17 per share. 84,585
04/23/2021 Stephen Hoge
President
100   Disposition at $175.34 per share. 17,534
04/23/2021 Stephen Hoge
President
1,400   Disposition at $174.46 per share. 244,244
04/23/2021 Stephen Hoge
President
4,639   Disposition at $173.81 per share. 806,304
04/23/2021 Stephen Hoge
President
2,200   Disposition at $172.81 per share. 380,182
04/23/2021 Stephen Hoge
President
1,000   Disposition at $171.77 per share. 171,770
04/23/2021 Stephen Hoge
President
5,100   Disposition at $170.18 per share. 867,918
04/23/2021 Stephen Hoge
President
561   Disposition at $169.18 per share. 94,909
04/23/2021 Stephen Hoge
President
10,000   Derivative/Non-derivative trans. at $0.99 per share. 9,900
04/23/2021 Stephen Hoge
President
5,000   Derivative/Non-derivative trans. at $10.9 per share. 54,500
04/22/2021 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $168.26 per share. 1,682,600
04/22/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Disposition at $168.26 per share. 1,110,516
04/22/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Derivative/Non-derivative trans. at $20.93 per share. 138,138
04/21/2021 Stéphane Bancel
Chief Executive Officer; Director
2,000   Gift at $0 per share. 0
04/21/2021 Stéphane Bancel
Chief Executive Officer; Director
9,000   Disposition at $158.6 per share. 1,427,400
04/21/2021 Juan Andres
See remarks
5,000   Disposition at $158.6 per share. 793,000
04/21/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
04/20/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Disposition at $160.32 per share. 1,058,112
04/20/2021 Lori M. Henderson
General Counsel and Secretary
6,600   Derivative/Non-derivative trans. at $20.93 per share. 138,138
04/19/2021 Juan Andres
See remarks
5,000   Disposition at $166.17 per share. 830,850
04/19/2021 Tal Zaks
Chief Medical Officer
100   Disposition at $167.56 per share. 16,756
04/19/2021 Tal Zaks
Chief Medical Officer
700   Disposition at $166.31 per share. 116,417
04/19/2021 Tal Zaks
Chief Medical Officer
462   Disposition at $165.04 per share. 76,248
04/19/2021 Tal Zaks
Chief Medical Officer
500   Disposition at $163.89 per share. 81,945
04/19/2021 Tal Zaks
Chief Medical Officer
1,250   Disposition at $162.65 per share. 203,312
04/19/2021 Tal Zaks
Chief Medical Officer
1,332   Disposition at $161.62 per share. 215,277
04/19/2021 Tal Zaks
Chief Medical Officer
656   Disposition at $160.48 per share. 105,274
04/19/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
04/19/2021 Tal Zaks
Chief Medical Officer
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
530   Disposition at $171.42 per share. 90,852
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
2,938   Disposition at $170.42 per share. 500,693
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
1,017   Disposition at $169.42 per share. 172,300
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
500   Disposition at $168.42 per share. 84,210
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
1,100   Disposition at $167.18 per share. 183,898
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
1,131   Disposition at $166.24 per share. 188,017
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
100   Disposition at $164.48 per share. 16,448
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
500   Disposition at $163.5 per share. 81,750
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
600   Disposition at $162.38 per share. 97,428
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
1,530   Disposition at $161.59 per share. 247,232
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
700   Disposition at $160.18 per share. 112,126
04/16/2021 Stéphane Bancel
Chief Executive Officer; Director
400   Disposition at $158.84 per share. 63,536

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
72 Purchases
324 Sales
430,181
11,111,593
Last 6 months
115 Purchases
610 Sales
728,544
11,955,230
Last 12 months
210 Purchases
1,075 Sales
3,496,668
40,188,127

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Tal Zaks
Chief Medical Officer
Dr. Melanie Ivarsson
Chief Development Officer
Ms. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
SVP-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Dr. Corinne Le Goff
Chief Commercial Officer
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Ms. Jennifer Ling Lee
Chief Accounting Officer
Ms. Tracey Franklin
Chief Human Resources Officer
Ms. Lori M. Henderson
Secretary & General Counsel
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.